Value of Ambulatory Arterial Stiffness Index and 24-h Pulse Pressure to Predict Progression of Albuminuria in Elderly People With Diabetes Mellitus

American Journal of Hypertension

Volumn 20, Issue 5, 2007, Pages 493-500

  Palmas, Walter ^a   Pickering, Thomas ^a   Eimicke, Joseph P ^b   Moran, Andrew ^c,d   Teresi, Jeanne ^b,e   Schwartz, Joseph E ^f   Field, Lesley ^a   Weinstock, Ruth S ^g,h   Shea, Steven ^a,i  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Research Division   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^f STONY BROOK UNIVERSITY   (United States)

^g SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ Department of Medicine   (United States)

Author keywords

Albuminuria; ambulatory blood pressure; arterial stiffness; diabetes mellitus; pulse pressure

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ALBUMINURIA; ARTERIOSCLEROSIS; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PULSE PRESSURE; STATISTICAL ANALYSIS; STATISTICAL MODEL; URINALYSIS;

AGED; ALBUMINURIA; ARTERIES; BLOOD PRESSURE MONITORING, AMBULATORY; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MONITORING, AMBULATORY; PROGNOSIS; PULSE; VASCULAR RESISTANCE;

EID: 34247589656     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.11.005     Document Type: Article

References (32)

1. MacLeod J.M., Lutale J., and Marshall S.M. Albumin excretion and vascular deaths in NIDDM. Diabetologia 38 (1995) 610-616
2. Rossing P., Hougaard P., Borch-Johnsen K., and Parving H.H. Predictors of mortality in insulin dependent diabetes: 10 year observational follow-up study. BMJ 313 (1996) 779-784
3. Ljungman S., Wikstrand J., Hartford M., and Berglund G. Urinary albumin excretion-a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 9 (1996) 770-778
4. Donnelly R, Yeung JM, Manning G: Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes. J Hypertens Suppl 21 Suppl 1 (2003) S7-S12
5. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., Halle J.P., Young J., Rashkow A., Joyce C., Nawaz S., and Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
6. Wachtell K., Ibsen H., Olsen M.H., Borch-Johnsen K., Lindholm L.H., Mogensen C.E., Dahlof B., Devereux R.B., Beevers G., de Faire U., Fyhrquist F., Julius S., Kjeldsen S.E., Kristianson K., Lederballe-Pedersen O., Nieminen M.S., Okin P.M., Omvik P., Oparil S., Wedel H., Snapinn S.M., and Aurup P. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139 (2003) 901-906
7. Spoelstra-de Man A.M., Brouwer C.B., Stehouwer C.D., and Smulders Y.M. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care 24 (2001) 2097-2101
8. Shahinfar S., Dickson T.Z., Ahmed T., Zhang Z., Ramjit D., Smith R.D., and Brenner B.M. Losartan in patients with type 2 diabetes and proteinuria: observations from the RENAAL Study. Kidney Int Suppl 82 (2002) 64-67
9. Fabre J., Balant L.P., Dayer P.G., Fox H.M., and Vernet A.T. The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int 21 (1982) 730-738
10. Klein R., Klein B.E., and Moss S.E. Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 16 (1993) 1325-1330
11. Olivarius Nde F., Andreasen A.H., Keiding N., and Mogensen C.E. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study Diabetes Care in General Practice, Denmark. Diabetologia 36 (1993) 1007-1016
12. Nielsen S., Schmitz A., Poulsen P.L., Hansen K.W., and Mogensen C.E. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study. Diabetes Care 18 (1995) 1434-1441
13. Poulsen P.L., Hansen K.W., and Mogensen C.E. Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients. Diabetes 43 (1994) 1248-1253
14. Lurbe E., Redon J., Kesani A., Pascual J.M., Tacons J., Alvarez V., and Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347 (2002) 797-805
15. Palmas W., Moran A., Pickering T., Eimicke J.P., Teresi J., Schwartz J.E., Field L., Weinstock R.S., and Shea S. Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension 48 (2006) 301-308
16. Li Y., Dolan E., Wang J.G., Thijs L., Zhu D.L., Staessen J.A., O'Brien E., and Stanton A. Ambulatory arterial stiffness index: determinants and outcome. Blood Press Monit 11 (2006) 107-110
17. Li Y., Wang J.G., Dolan E., Gao P.J., Guo H.F., Nawrot T., Stanton A.V., Zhu D.L., O'Brien E., and Staessen J.A. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension 47 (2006) 359-364
18. Dolan E., Thijs L., Li Y., Atkins N., McCormack P., McClory S., O'Brien E., Staessen J.A., and Stanton A.V. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 47 (2006) 365-370
19. Leoncini G., Ratto E., Viazzi F., Vaccaro V., Parodi A., Falqui V., Conti N., Tomolillo C., Deferrari G., and Pontremoli R. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension 48 (2006) 364-365
20. Shea S., Starren J., Weinstock R.S., Knudson P.E., Teresi J., Holmes D., Palmas W., Field L., Goland R., Tuck C., Hripcsak G., Capps L., and Liss D. Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) project: rationale and design. J Am Med Inform Assoc 9 (2002) 49-62
21. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-S266.
22. Bild D.E., Bluemke D.A., Burke G.L., Detrano R., Diez Roux A.V., Folsom A.R., Greenland P., Jacob Jr. D.R., Kronmal R., Liu K., Nelson J.C., O'Leary D., Saad M.F., Shea S., Szklo M., and Tracy R.P. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156 (2002) 871-881
23. Pickering T.G. Ambulatory Blood Pressure (1994), Spacelabs Medical, Redmond, WA
24. Roman M.J., Pickering T.G., Schwartz J.E., Cavallini M.C., Pini R., and Devereux R.B. Is the absence of a normal nocturnal fall in blood pressure (nondipping) associated with cardiovascular target organ damage?. J Hypertens 15 (1997) 969-978
25. McNeil B.J., and Hanley J.A. Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Decis Making 4 (1984) 137-150
26. Hedblad B., Ogren M., Engstrom G., Wollmer P., and Janzon L. Heterogeneity of cardiovascular risk among smokers is related to degree of carbon monoxide exposure. Atherosclerosis 179 (2005) 177-183
27. Kleinbaum D.G., and Klein M. Survival Analysis. 2nd ed. (2005), Springer, New York, NY
28. Benetos A., and Lacolley P. From 24-hour blood pressure measurements to arterial stiffness: a valid short cut?. Hypertension 47 (2006) 327-328
29. Nelson R.G., Knowler W.C., Pettitt D.J., Saad M.F., Charles M.A., and Bennett P.H. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med 151 (1991) 1761-1765
30. Gatling W., Knight C., Mullee M.A., and Hill R.D. Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabet Med 5 (1988) 343-347
31. Hutchison A.S., O'Reilly D.S., and MacCuish A.C. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem 34 (1988) 2019-2021
32. Chaiken R.L., Khawaja R., Bard M., Eckert-Norton M., Banerji M.A., and Lebovitz H.E. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Diabetes Care 20 (1997) 709-713